Dr. Michael J. Toole, MD

Dr. Toole practices at Parkview Regional Medical Center in Fort Wayne, Indiana, part of Parkview Health System.

Dr. Toole's NPI, 1396008918, was assigned on June 19, 2012. Dr. Toole holds Indiana license 01079379A.

Dr. Toole's primary practice is Parkview Regional Medical Center, at 11109 Parkview Plaza Drive, Fort Wayne, IN 46845 in Allen County. The practice phone is (260) 266-1195.

Dr. Toole's primary practice is Parkview Regional Medical Center in Fort Wayne, Indiana, part of Parkview Health System. Dr. Toole is also affiliated with Parkview Whitley Hospital. The medical group on file is Parkview Physicians Group. Dmand AI also links Dr. Toole to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Toole practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Toole's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Toole's licenses on file in 2 states: Indiana and Michigan.

CMS data shows 976 Medicare services from Dr. Toole across 10 procedure codes in 2024, for 308 Medicare patients. Medicare paid $64,372 for them.

CMS counts 308 Medicare patients who saw Dr. Toole in 2024. The largest group is 65 to 74, with 138 patients. 73% of them have high blood pressure, and 71% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Toole's median patient age at 74, with 44% women.

In 2024, Dr. Toole wrote 1,969 Medicare Part D claims for 290 patients. 58% of them were for generic drugs. CMS names the drug for 1,796 of them, across 41 drugs with 11 or more claims each, at $11,812,406 in total drug cost. In 2023, CMS named 1,327 claims across 35 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Toole for performance year 2024, reported as part of a group. Dr. Toole accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Toole as offering telehealth.

Dmand AI links 13 papers to Dr. Toole, published from 2010 to 2023. 2014 was the busiest year, with 2. The most frequent topics are Laos, Condoms and Disaster Planning. Dr. Toole's most frequent co-authors are Ramin Asgary, MD, David Michael Gill and Kenneth Frederick Grossmann, MD.

CMS Open Payments shows 404 general payments to Dr. Toole from 50 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 42% of the total. Rigel Pharmaceuticals, Inc. paid the most, $9,919.